Wei Li is a Principal Scientist at Cabaletta Bio since January 2024, with extensive experience in the biotechnology and pharmaceutical industries. Wei Li served as Project Lead for CAR-T Analytical Transfer and Clinical Manufacturing and Science Support at Celgene from February 2019 to December 2023, focusing on analytical activities for CAR-T drug product release. Previous roles include Senior Manager and Senior Bioengineer at Bristol Myers Squibb and Senior Scientist in Translational Operations at Spark Therapeutics, Inc. Wei Li also worked as Senior Principal Biologist at Eisai Research Institute and Principal Biologist at BioTransplant Inc. Wei Li holds an MBA in Finance from the Carroll School of Management at Boston College, completed a Postdoctoral training at Indiana University School of Medicine, and earned a Bachelor's degree in Medicine (M.D. equivalent) from XiangYa School of Medicine, CSU, Hunan, China.
This person is not in any teams
This person is not in any offices